XML 33 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Operations and Comprehensive Income (Loss) (USD $)
 3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Revenues:    
Revenue from collaborative research $ 14,400,679 $ 10,066,957
Grant revenue 317,918 531,070
Total revenues 14,718,597 10,598,027
Costs and expenses:    
Research and development 14,568,754 10,096,787
General and administrative 3,258,587 3,832,900
Total costs and expenses 17,827,341 13,929,687
Income (loss) from operations (3,108,744) (3,331,660)
Other income (expense) 409 (34,241)
Net comprehensive income (loss) $ (3,108,335) $ (3,365,901)
Basic and diluted net income (loss) per common share $ (0.12) $ (2.93)
Weighted average common shares outstanding, basic and diluted 26,262,356 1,148,694